{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:16:49Z","timestamp":1772896609133,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.athplu.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:59:17Z","timestamp":1695326357000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["High-density lipoprotein cholesterol and multiple myeloma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"54","author":[{"given":"Anastasios","family":"Makris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Pagkali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Nikolousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodosios D.","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-5075","authenticated-orcid":false,"given":"Aris P.","family":"Agouridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athplu.2023.09.003_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.athplu.2023.09.003_bib2","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.athplu.2023.09.003_bib3","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.athplu.2023.09.003_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0076-6879(86)28063-5","article-title":"Comparative analysis of mammalian plasma lipoproteins","volume":"128","author":"Chapman","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.athplu.2023.09.003_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","article-title":"Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells","volume":"41","author":"Negre-Salvayre","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.athplu.2023.09.003_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1189731","article-title":"ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation","volume":"328","author":"Yvan-Charvet","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.athplu.2023.09.003_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-020-00963-6","article-title":"Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals","volume":"13","author":"Pedersen","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.athplu.2023.09.003_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41375-020-01081-5","article-title":"Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy","volume":"35","author":"Jeong","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.athplu.2023.09.003_bib9","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2023.09.003_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.plipres.2018.06.001","article-title":"High density lipoprotein cholesterol and cancer: marker or causative?","volume":"71","author":"Pirro","year":"2018","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.athplu.2023.09.003_bib11","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2019.190824","article-title":"Cholesterol levels provide prognostic information in patients with multiple myeloma","volume":"66","author":"Liu","year":"2020","journal-title":"Clin Lab"},{"key":"10.1016\/j.athplu.2023.09.003_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/157016111794519354","article-title":"Hypocholesterolemia","volume":"9","author":"Moutzouri","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.athplu.2023.09.003_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.athplu.2023.09.003_bib14","series-title":"In the newcastle-ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.athplu.2023.09.003_bib15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.dsx.2020.08.027","article-title":"Glucocorticoid induced diabetes and lipid profiles disorders amongst lymphoid malignancy survivors","volume":"14","author":"Dehghani","year":"2020","journal-title":"Diabetes Metabol Syndr"},{"key":"10.1016\/j.athplu.2023.09.003_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000355826","article-title":"Multiple myeloma: relationship to antioxidant esterases","volume":"23","author":"Ellidag","year":"2014","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.athplu.2023.09.003_bib17","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.7314\/APJCP.2014.15.22.9847","article-title":"Decreased HDL-dependent paraoxonase and arylesterase enzyme activity may indicate a worse prognosis in multiple myeloma","volume":"15","author":"Ellidag","year":"2014","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.athplu.2023.09.003_bib18","first-page":"204","article-title":"Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma","volume":"21","author":"Faridvand","year":"2016","journal-title":"Redox Rep"},{"key":"10.1016\/j.athplu.2023.09.003_bib19","first-page":"675","article-title":"Quantitative abnormalities of lipoprotein particles in multiple myeloma","volume":"25","author":"Hachem","year":"1987","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.athplu.2023.09.003_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0005-2760(88)90291-3","article-title":"Evidence for qualitative abnormalities in high-density lipoproteins from myeloma patients: the presence of amyloid A protein could explain HDL modifications","volume":"963","author":"Hachem","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.athplu.2023.09.003_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0145-2126(99)00083-1","article-title":"Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma","volume":"23","author":"Hungria","year":"1999","journal-title":"Leuk Res"},{"key":"10.1016\/j.athplu.2023.09.003_bib22","first-page":"13","article-title":"Serum lipids and risk of obesity-related cancers in postmenopausal women","volume":"29","author":"Kabat","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.athplu.2023.09.003_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/nbm.1940080308","article-title":"Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma","volume":"8","author":"Kuliszkiewicz-Janus","year":"1995","journal-title":"NMR Biomed"},{"key":"10.1016\/j.athplu.2023.09.003_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2478\/s11658-008-0014-9","article-title":"Lipid changes occurring in the course of hematological cancers","volume":"13","author":"Kuliszkiewicz-Janus","year":"2008","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.athplu.2023.09.003_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/pgmj.60.705.449","article-title":"Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies","volume":"60","author":"Levy","year":"1984","journal-title":"Postgrad Med"},{"key":"10.1016\/j.athplu.2023.09.003_bib26","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.7150\/jca.31357","article-title":"Identification of high serum apolipoprotein A1 as a favorable prognostic indicator in patients with multiple myeloma","volume":"10","author":"Liang","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.athplu.2023.09.003_bib27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40620-020-00926-7","article-title":"A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study","volume":"34","author":"Lin","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.athplu.2023.09.003_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071617","article-title":"Association between cholesterol level and the risk of hematologic malignancy according to menopausal status: a Korean nationwide cohort study","volume":"10","author":"Jung","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.athplu.2023.09.003_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacl.2020.04.001","article-title":"Progressively decreasing plasma high-density lipoprotein cholesterol levels preceding diagnosis of smoldering myeloma","volume":"14","author":"Tavori","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.athplu.2023.09.003_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030540","article-title":"Lipid level, lipid variability, and risk of multiple myeloma: a nationwide population-based study of 3,527,776 subjects","volume":"13","author":"Choi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.athplu.2023.09.003_bib32","first-page":"1162","article-title":"[Serum lipid levels and their prognostic significance in patients with multiple myeloma]","volume":"30","author":"Chen","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.athplu.2023.09.003_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cccn.2005.02.008","article-title":"Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein","volume":"358","author":"Tsai","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.athplu.2023.09.003_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1600-0609.1985.tb00774.x","article-title":"Chylomicronaemia in multiple myeloma","volume":"34","author":"Aviram","year":"1985","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib35","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.7150\/jca.69321","article-title":"A new prediction model integrated serum lipid profile for patients with multiple myeloma","volume":"13","author":"Wang","year":"2022","journal-title":"J Cancer"},{"key":"10.1016\/j.athplu.2023.09.003_bib36","first-page":"146","article-title":"The relationship between hematological malignancy and lipid profile","volume":"36","author":"Ozturk","year":"2021","journal-title":"Medeni Med J"},{"key":"10.1016\/j.athplu.2023.09.003_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exphem.2021.02.007","article-title":"Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation","volume":"97","author":"Veskovski","year":"2021","journal-title":"Exp Hematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00223-008-9123-8","article-title":"The effects of zoledronic acid on serum lipids in multiple myeloma patients","volume":"82","author":"Gozzetti","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.athplu.2023.09.003_bib39","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO;2-Q","article-title":"Serum lipids and lipoprotein disorders in cancer patients","volume":"60","author":"Alexopoulos","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.athplu.2023.09.003_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(82)90543-5","article-title":"Plasma lipid alterations in leukemia and lymphoma","volume":"72","author":"Spiegel","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.athplu.2023.09.003_bib41","first-page":"343","article-title":"Return to normal values of lipid pattern after effective chemotherapy in acute lymphoblastic leukemia","volume":"81","author":"Scribano","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.athplu.2023.09.003_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1874192401105010035","article-title":"Malignancy-associated dyslipidemia","volume":"5","author":"Bielecka-Dabrowa","year":"2011","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.athplu.2023.09.003_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOL.0000000000000333","article-title":"Effect of inflammation on HDL structure and function","volume":"27","author":"Feingold","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.athplu.2023.09.003_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s15010-017-1022-3","article-title":"Lipid testing in infectious diseases: possible role in diagnosis and prognosis","volume":"45","author":"Filippas-Ntekouan","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.athplu.2023.09.003_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jacl.2012.06.009","article-title":"New-onset extremely low levels of high-density lipoprotein cholesterol","volume":"6","author":"Agouridis","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.athplu.2023.09.003_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.athplu.2021.08.007","article-title":"High-density lipoprotein cholesterol: a marker of COVID-19 infection severity?","volume":"44","author":"Agouridis","year":"2021","journal-title":"Atheroscler Plus"},{"key":"10.1016\/j.athplu.2023.09.003_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF01468673","article-title":"Antibodies against lipoproteins in man. Occurrence and biological significance","volume":"53","author":"Riesen","year":"1975","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.athplu.2023.09.003_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00392-010-0186-y","article-title":"Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia","volume":"99","author":"van Gorselen","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.athplu.2023.09.003_bib49","first-page":"245","article-title":"[Report of 2 new cases of unusual association of myeloma and hyperlipidemia]","volume":"169","author":"Candel Monserrate","year":"1983","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.athplu.2023.09.003_bib50","first-page":"360","article-title":"[Unusual multiple myeloma: biclonal gammopathy associated with hyperlipidemia]","volume":"31","author":"Rodriguez Fuchs","year":"1986","journal-title":"Sangre"},{"key":"10.1016\/j.athplu.2023.09.003_bib51","first-page":"398","article-title":"Abnormal proteins in myeloma","volume":"5","author":"Waldenstrom","year":"1952","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.athplu.2023.09.003_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0021-9150(77)90111-3","article-title":"Autoimmune hyperlipidemia","volume":"26","author":"Beaumont","year":"1977","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2023.09.003_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI111951","article-title":"Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin","volume":"76","author":"Kilgore","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.athplu.2023.09.003_bib54","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/clinchem\/39.5.917","article-title":"IgA anti-lipoprotein antibodies in autoimmune dyslipidemia are restricted to IgA1 subclass","volume":"39","author":"Rostoker","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.athplu.2023.09.003_bib55","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.athplu.2023.09.003_bib56","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/2047487320914756","article-title":"HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies","volume":"27","author":"Zhong","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.athplu.2023.09.003_bib57","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/oxfordjournals.aje.a008686","article-title":"Sex difference in high density lipoprotein cholesterol in six countries","volume":"143","author":"Davis","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.athplu.2023.09.003_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010202","article-title":"Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women","volume":"12","author":"Ko","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.athplu.2023.09.003_bib59","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M113.468967","article-title":"The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects","volume":"288","author":"Zamanian-Daryoush","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.athplu.2023.09.003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114654","article-title":"Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs","volume":"196","author":"Patel","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.athplu.2023.09.003_bib61","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.21873\/anticanres.11566","article-title":"In vitro apoptosis induction by fenofibrate in lymphoma and multiple myeloma","volume":"37","author":"Schmeel","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.athplu.2023.09.003_bib62","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1200\/JCO.2016.68.3482","article-title":"Statins are associated with reduced mortality in multiple myeloma","volume":"34","author":"Sanfilippo","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.athplu.2023.09.003_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008147","article-title":"Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia","volume":"4","author":"Khanim","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2023.09.003_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000505992","article-title":"The association between metabolic syndrome and multiple myeloma","volume":"144","author":"Ragbourne","year":"2021","journal-title":"Acta Haematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib65","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.athplu.2023.09.003_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221086755","article-title":"Cardiovascular-specific mortality among multiple myeloma patients: a population-based study","volume":"13","author":"Yin","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib67","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00277-022-04959-9","article-title":"Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016","volume":"101","author":"Toppila","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib68","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/ejh.13597","article-title":"Comorbidities in multiple myeloma and implications on survival: a population-based study","volume":"106","author":"Sverrisd\u00f3ttir","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.athplu.2023.09.003_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11936-018-0618-y","article-title":"Cardiovascular complications of multiple myeloma treatment: evaluation, management, and prevention","volume":"20","author":"Lee","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.athplu.2023.09.003_bib70","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1111\/bph.15653","article-title":"Targeting lipid metabolism in multiple myeloma cells: rational development of a synergistic strategy with proteasome inhibitors","volume":"178","author":"Xu","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.athplu.2023.09.003_bib71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pathol.2018.11.006","article-title":"Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment","volume":"51","author":"Carr","year":"2019","journal-title":"Pathology"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089523000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089523000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:44:36Z","timestamp":1763023476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089523000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":71,"alternative-id":["S2667089523000408"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2023.09.003","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoprotein cholesterol and multiple myeloma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}